Professional Documents
Culture Documents
Case 333
Case 333
Patient’s Data
In type 2 diabetes, there are primarily two interrelated problems at work. Your pancreas does not produce enough insulin — a hormone that regulates the movement of sugar
into your cells — and cells respond poorly to insulin and take in less sugar.
Type 2 diabetes used to be known as adult-onset diabetes, but both type 1 and type 2 diabetes can begin during childhood and adulthood. Type 2 is more common in older
adults, but the increase in the number of children with obesity has led to more cases of type 2 diabetes in younger people.
There's no cure for type 2 diabetes, but losing weight, eating well and exercising can help you manage the disease. If diet and exercise aren't enough to manage your blood
sugar, you may also need diabetes medications or insulin therapy.
Signs and symptoms of type 2 diabetes often develop slowly. In fact, you can be living with type 2 diabetes for years and not know it. When signs and symptoms are
present, they may include:
Increased thirst
Frequent urination
Increased hunger
Fatigue
Blurred vision
Slow-healing sores
Frequent infections
Pancreas Pancreas endocrine function involves the secretion of insulin (produced by beta cells) and glucagon (produced by alpha cells) within the pancreatic islets. These two hormones
regulate the rate of glucose metabolism in the body.
The alpha cell produces the hormone glucagon and makes up approximately 20 percent of each islet. Low blood glucose levels stimulate the release of glucagon.
The beta cell produces the hormone insulin and makes up approximately 75 percent of each islet. Elevated blood glucose levels stimulate the release of insulin.
The delta cell accounts for four percent of the islet cells and secretes the peptide hormone somatostatin. Recall that somatostatin is also released by the
hypothalamus, stomach and intestines. An inhibiting hormone, pancreatic somatostatin inhibits the release of both glucagon and insulin.
The pancreatic polypeptide cell (PP cell) accounts for about one percent of islet cells and secretes the pancreatic polypeptide hormone. It is thought to play a role in
appetite, as well as in the regulation of pancreatic exocrine and endocrine secretions. Pancreatic polypeptide released following a meal may reduce further food
consumption; however, it is also released in response to fasting.
Glucagon
Glucagon stimulates the liver to convert its stores of glycogen back into glucose. This response is known as glycogenolysis. The glucose is then released into the
circulation for use by cells throughout the body.
Glucagon stimulates the liver to take up amino acids from the blood and convert them into glucose. This response is known as gluconeogenesis.
Glucagon stimulates lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. Some of the free glycerol released into the bloodstream travels
to the liver, which converts the glycerol into glucose. This is also a form of gluconeogenesis.
Insulin
The primary function of insulin is to facilitate the uptake of glucose into body cells. Red blood cells, as well as cells of the brain, liver, kidneys, and the lining of the small
intestine, do not have insulin receptors on their cell membranes and do not require insulin for glucose uptake. Although all other body cells do require insulin if they are to
take glucose from the bloodstream, skeletal muscle cells and adipose cells are the primary targets of insulin.
PATHOPHYSIOLOGY
In type 2 diabetes, the body either produces inadequate amounts of insulin to meet the
demands of the body or insulin resistance has developed. Insulin resistance refers to when cells of the body such as the muscle, liver and fat cells fail to respond to insulin,
even when levels are high. In fat cells, triglycerides are instead broken down to produce free fatty acids for energy; muscle cells are deprived of an energy source and liver
cells fail to build up glycogen stores.
This also leads to an overall rise in the level of glucose in the blood. Glycogen stores become markedly reduced and there is less glucose available for release when it may be
needed. Obesity and lack of physical activity are thought to be major causes of insulin resistance.
After:
Inform patient
DRUG STUDY
about possible
side effects of
the drugs
Instruct patient
to be cautious
of the
contraindication
s of the drugs
.
Drug name Mechanism of action Indication Adverse Nursing
reaction responsibilities
Generic Mannitol is an osmotic diuretic that is OSMITROL Injection CNS: Confusion, BEFORE:
Name: metabolically inert in humans and (Mannitol Injection, headache Check vital signs and
Mannitol occurs naturally, as a sugar or sugar USP) is indicated for: urine output.
alcohol, in fruits and vegetables. The promotion of EENT: Blurred Assess signs of
Brand Name: Mannitol elevates blood plasma diuresis, in the vision, Rhinitis dehydration and
Osmitrol osmolality, resulting in enhanced flow of prevention and/or muscle weakness
water from tissues, including the brain treatment of the oliguric CV: Monitor neurologic
Classification and cerebrospinal fluid, into interstitial phase of acute renal Transient volume status and intracranial
Osmoc fluid and plasma. As a result, cerebral failure before expansion, pressure
edema, elevated intracranial pressure, irreversible renal failure Chest pain ,CHF,
Dosage: 1 and cerebrospinal fluid volume and becomes established; pulmonary edema, DURING:
g/tab, 1 tab pressure may be reduced. As a diurectic The reduction of tachycardia Administer over
Route: PO mannitol induces diuresis because it is intracranial pressure 30min
Frequency: not reabsorbed in the renal tubule, and treatment of GI: Nausea, thirst, Monitor urine output
OD thereby increasing the osmolality of the cerebral edema by vomiting and refer in
glomerular filtrate, facilitating excretion reducing brain mass; accordance with
of water, and inhibiting the renal tubular The reduction of GU: renal failure, parameters set by
reabsorption of sodium, chloride, and elevated intraocular urinary retention physician
other solutes. Mannitol promotes the pressure when the Ensure safety and
urinary excretion of toxic materials and pressure cannot be F&E: Dehydration, report signs of
protects against nephrotoxicity by lowered by other hyperkalemia, electrolyte imbalance
preventing the concentration of toxic means, and Promoting hypernatremia,
substances in the tubular fluid. As an the urinary excretion of hypokalemia, AFTER:
Antiglaucoma agent mannitol levates toxic substances. hyponatremia Check effectiveness
blood plasma osmolarity, resulting in of therapy
enhanced flow of water from the eye CONTRAINDICATIONS Local: Phlebitis@ Continuously monitor
into plasma and a consequent reduction OSMITROL Injection IV site neurologic status and
in intraocular pressure. As a renal (Mannitol Injection, urine output
function diagnostic aid mannitol is freely USP) is contraindicated Reassess
filtered by the glomeruli with less than in patients with: Well signs/symptoms of
10% tubular reabsorption. Therefore, its established anuria due dehydration
urinary excretion rate may serve as a to severe renal disease, Watch out for
measurement of glomerular filtration Severe pulmonary abnormal responses
rate (GFR). congestion or frank
The exact mechanism of action of pulmonary edema,
inhaled mannitol in the symptomatic Active intracranial
maintenance treatment of cystic fibrosis bleeding except during
remains unclear.7,8 It is hypothesized craniotomy, Severe
that mannitol produces an osmotic dehydration,
gradient across the airway epithelium Progressive renal
that draws fluid into the extracellular damage or dysfunction
space and alters the properties of the after institution of
airway surface mucus layer, allowing mannitol therapy,
easier mucociliary clearance. including increasing
oliguria and azotemia,
https://go.drugbank.com/drugs/DB00742 and Progressive heart
failure or pulmonary
congestion after
institution of mannitol
therapy
Drug Name Classification Mechanism of Action Indication Contraindication Adverse reactions Nursing
Responsibilities
Generic Name: Proton pump Inhibits both basal Duodenal and Known Occasionally Assess underlying
inhibitors. and stimulated gastric gastric ulcer, hypersensitivity to headache or condition before
Pantoprazole acid secretion by moderate and any of the diarrhea. Isolated therapy and
suppressing the final severe reflux constituents of cases of edema, thereafter to monitor
Generic name: step in acids esophagitis. Pantoloc or of the blurred vision, drug effectiveness.
production, through Eradication of combination fever, dizziness, Assess GI
Pantoloc the inhabitation of the H. pylori in partners. Mild thrombophlebitis, symptoms:
proton pump by patient with gastrointestinal depression or epigastric/abdominal
Patient dose: binding to and peptic ulcer, complaints eg, myalgia subsiding pain, bleeding and
40 mg IVTT/1 inhibiting hydrogen- pathological nervous after termination of anorexia. Monitor for
vial, after potassium adenosine hyper secretory dyspepsia. therapy. possible drug
breakfast triphosphatase, the conditions. Pantoloc must not induced adverse
enzyme system Symptomatic be used in reaction.
located at the improvement combination
secretory surface of and healing of treatment for
the gastric parietal mild reflux eradication of H.
cell. esophagitis. pylori in patients
Prevention with moderate to
gastro-duodenal severe hepatic or
ulcers induced renal dysfunction.
by NSAID in
patients at risk
with a need for
continuous
NSAID
treatment.
Drug Name Classification Mechanism of Action Indication Contraindication Side Effects/ Nursing
Adverse reactions Responsibilities
Generic Name: Calcium channel Inhibits calcium ion Chronic stable In cancer patients, CNS: Before:
blockers from entering the angina with bone Headache,
Nicardipine “slow channels” or metastasis and in dizziness, Inform prescriber
select voltage- Management of patients with somnolence, if you are/or
Generic name: sensitive areas of essential ventricular paresthesia intend to become
Cardene vascular smooth hypertension fibrillation, pregnant. Breast
muscle and hypercalcemia, CV: feeding is not
Patient dose: myocardium during hypophosphatemia, Flushing recommended.
10 mg + 90 cc depolarization, or renal calculi palpitations,
PNSS at 20 cc/hr producing a relaxation tachycardia, Inform prescriber
of coronary vascular peripheral edema, of all prescription,
Route: Oral smooth muscle and increased angina, OTC
coronary vasodilation; hypotension medications, or
increases myocardial orthostasis herbal products
oxygen delivery in you are taking,
patients with Skin: Rash and any allergies
vasospastic angina. you have.
GI:
Nausea, dry mouth
During:
GU: polyuria
Report
MS: myalgia, immediately any
weakness swelling,
redness, burning,
Other: Diaphoresis or pain at infusion
site.
Do not crush or
chew sustained
release forms;
swallow whole.
After:
May cause
orthostatic
hypotension
(change position
slowly from sitting
or lying to
standing, or when
climbing stairs)
May cause
dizziness or
fatigue (use
caution when
driving or
engaging in tasks
that require
alertness until
response to drug
is known)
May cause
nausea and dry
mouth ( small
frequent meals,
frequent mouth
care, chewing
gum, or sucking
lozenges may
help).
Dependent:
1. Teach the client to
follow the drug
regimen as
prescribed by
physician.
Reference:
Doenges, E.,
Moorhouse, F. M.,
& Murr A. 2010.
Nursing Care
Plans: Guidelines
for Individualizing
Client Care
Across the Life
Span
EVALUATION
After 8 hours of nursing intervention, the patient was able to have a normal urinary elimination pattern and was able to
show full understanding regarding the condition.
After 4 days of nursing intervention, the patient Identified the causative factors
And demonstrated behaviors or techniques to cope with condition properly.